ARDX
HOLD / NEUTRALMeanRevComposite
38.80
Technical
6.70
Fundamental
49.50
Rank
—
Price
3.03
Hurst
0.27
As of
Nov 4, 2026
Daily
Ardelyx Inc
HEALTHCAREBIOTECHNOLOGYArdelyx is a biopharmaceutical firm based in Fremont, California that focuses on developing and commercializing medications to treat conditions affecting the kidneys and the intersection of heart and kidney disease across global markets.
Market cap
$782.3M
P/E (trailing)
—
P/E (forward)
8.64
PEG ratio
-0.08
Dividend yield
—
Beta
0.77
52w range
2.96 – 8.40
Return on equity
-38.60%
Profit margin
-12.30%
Revenue growth
+23.80%
Earnings growth
0.00%
Price history
1Y: 3.03 (-50.0%) · range 3.00–7.99
Cycle position
17/ 100 cycle scoreENTRY ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 66 · GOOD SETUP · exit proximity 0
Conviction
49/ 100 · maturity 14%
VScore.0919
Buildup.3035
EMA entry setup.3866
Fundamentals.2350
Volume profile
POC
3.42
Price vs POC
-11.3%
Overhead supply
97%
Runway
+1.0%
Value area 2.96–5.22 · 97% of 120d volume overhead · heavy supply
Get an AI analyst's read on this ticker.Open the AI analyst
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.967 | Nov 4, 2026 |
Pattern & cluster
Pattern
NEUTRAL
Cluster
NEUTRALForward returns
Not yet labeled — the study prices these as positions mature.